Seyed Ramin Radfar
Dados Biográficos
| ID | 6070231 |
|---|---|
| NOME | Seyed Ramin Radfar |
| PRENOMES | Seyed Ramin |
| SOBRENOME | Radfar |
| ASSINATURA | RADFAR S R |
| AFILIAÇÕES | University of California, Los Angeles |
| ORCID | 0000-0003-1673-6154 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 10 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 10 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2010 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2023 |
| ÍNDICE H | 0 |
Retention rate in methadone maintenance treatment and factors associated among referred patients from the compulsory residential centers compared to voluntary patients
Although the average treatment adherence time for non-referred patients was about 60 days higher than those referred from compulsory residential centers, this study found no significant differences in retention days and a one-year retention rate. Further studies with larger sample sizes and longer follow-ups are needed to explore the efficacy of compulsory treatment methods in Iran
Substance use policy and practice in the Covid-19 pandemic
The COVID-19 pandemic has created an unprecedented natural experiment in drug policy, treatment delivery, and harm reduction strategies by exposing wide variation in public health infrastructures and social safety nets around the world. Using qualitative data including ethnographic methods, questionnaires, and semi-structured interviews with people who use drugs (PWUD) and Delphi-method with experts from field sites spanning 13 different countrie…
How Substance Use Treatment Services in Iran Survived Despite a Dual Catastrophic Situation
Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran
Reorganization of Substance Use Treatment and Harm Reduction Services During the Covid-19 Pandemic
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm redu…
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 Covid-19 Pandemic
Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and "lockdown" measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible do…
Coordination, cooperation, and creativity within harm reduction networks in Iran
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran
Integration of outpatient alcohol treatment services in substance abuse treatment centers
Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran
Sem obras proeminentes nesta página.
Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran
Integration of outpatient alcohol treatment services in substance abuse treatment centers
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran
Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran
Reorganization of Substance Use Treatment and Harm Reduction Services During the Covid-19 Pandemic
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm redu…
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 Covid-19 Pandemic
Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and "lockdown" measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible do…
Coordination, cooperation, and creativity within harm reduction networks in Iran
Substance use policy and practice in the Covid-19 pandemic
The COVID-19 pandemic has created an unprecedented natural experiment in drug policy, treatment delivery, and harm reduction strategies by exposing wide variation in public health infrastructures and social safety nets around the world. Using qualitative data including ethnographic methods, questionnaires, and semi-structured interviews with people who use drugs (PWUD) and Delphi-method with experts from field sites spanning 13 different countrie…
How Substance Use Treatment Services in Iran Survived Despite a Dual Catastrophic Situation
Retention rate in methadone maintenance treatment and factors associated among referred patients from the compulsory residential centers compared to voluntary patients
Although the average treatment adherence time for non-referred patients was about 60 days higher than those referred from compulsory residential centers, this study found no significant differences in retention days and a one-year retention rate. Further studies with larger sample sizes and longer follow-ups are needed to explore the efficacy of compulsory treatment methods in Iran
Medicine (10 obras) · Environmental health (9 obras) · HIV, Drug Use, Sexual Risk (7 obras) · Psychiatry (6 obras) · Population (5 obras) · Coronavirus disease 2019 (COVID-19 (4 obras) · Internal Medicine (4 obras) · Pandemic (4 obras) · Public health (4 obras) · Demography (3 obras)